Skip to content

Insider · CIK 0001680329

Emma Reeve

director

Files at PTCT (PTC THERAPEUTICS, INC.), WHWK (Whitehawk Therapeutics, Inc.). First filing Sep 16, 2025, latest Sep 16, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $934k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

PTCT: PTC THERAPEUTICS, INC.

PTCTOct 9, 2026 · close 64.70

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
39Weak
PTCTsell 510b5-1
PTC THERAPEUTICS, INC.
$934k
15,705 shares
-103%+89% from low0% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 11, 2025PTCT
PTC THERAPEUTICS, INC.
SOpen-market sale
Common Stock10b5-1
-3,534$59.50$210k11,666Sep 16, 2025
Sep 11, 2025PTCT
PTC THERAPEUTICS, INC.
SOpen-market sale
Common Stock10b5-1
-1,334$59.50$79k10,332Sep 16, 2025
Sep 11, 2025PTCT
PTC THERAPEUTICS, INC.
MOption exercise
Common Stock10b5-1
+10,000$25.69$257k20,332Sep 16, 2025
Sep 11, 2025PTCT
PTC THERAPEUTICS, INC.
SOpen-market sale
Common Stock10b5-1
-10,000$59.50$595k10,332Sep 16, 2025
Sep 11, 2025PTCT
PTC THERAPEUTICS, INC.
MOption exercise
Common Stock10b5-1
+837$33.63$28k11,169Sep 16, 2025
Sep 11, 2025PTCT
PTC THERAPEUTICS, INC.
SOpen-market sale
Common Stock10b5-1
-837$59.50$50k10,332Sep 16, 2025
Sep 11, 2025PTCT
PTC THERAPEUTICS, INC.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-10,000$0.00$00Sep 16, 2025
Sep 11, 2025PTCT
PTC THERAPEUTICS, INC.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-837$0.00$00Sep 16, 2025
Jun 12, 2025WHWK
Whitehawk Therapeutics, Inc.
AGrant or award
Stock Option (right to buy)derivative
+40,006$0.00$040,006Jun 16, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Emma Reeve: insider trades and track record | InsiderTell